Monika Davare

Assistant Professor

  • 3173 Citations
  • 26 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Monika Davare is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Phosphotransferases Medicine & Life Sciences
Medulloblastoma Medicine & Life Sciences
Calcium-Calmodulin-Dependent Protein Kinase Type 1 Medicine & Life Sciences
Calcium-Calmodulin-Dependent Protein Kinases Medicine & Life Sciences
Cyclic AMP-Dependent Protein Kinases Medicine & Life Sciences
Neurons Medicine & Life Sciences
Protein Kinases Medicine & Life Sciences
Phosphorylation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 3173 Citations
  • 26 h-Index
  • 42 Article
  • 1 Comment/debate
  • 1 Editorial

A blast from the past: ROS1 on the brain

Odintsov, I., Somwar, R. & Davare, M., Mar 1 2019, In : Oncotarget. 10, 18, p. 1664-1666 3 p.

Research output: Contribution to journalEditorial

Glioma
Phosphotransferases
Brain
Neoplasms

A ribose modification of Spinach aptamer accelerates lead(ii) cation association: In vitro

Savage, J. C., Shinde, P., Bächinger, H. P., Davare, M. & Shinde, U., Jan 1 2019, In : Chemical Communications. 55, 42, p. 5882-5885 4 p.

Research output: Contribution to journalArticle

Ribose
Cations
Lead
Positive ions
Fluorescence
2 Citations (Scopus)

Discovery and characterization of recurrent, targetable ALK fusions in leiomyosarcoma

Davis, L., Nusser, K. D., Przybyl, J., Pittsenbarger, J., Hofmann, N. E., Varma, S., Vennam, S., Debiec-Rychter, M., van de Rijn, M. & Davare, M., Mar 1 2019, In : Molecular Cancer Research. 17, 3, p. 676-685 10 p.

Research output: Contribution to journalArticle

Leiomyosarcoma
Phosphotransferases
Sarcoma
Smooth Muscle Myocytes
Neoplasms
1 Citation (Scopus)

Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes

Hosseini, M. M., Kurtz, S. E., Abdelhamed, S., Mahmood, S., Davare, M., Kaempf, A., Elferich, J., McDermott, J. E., Liu, T., Payne, S. H., Shinde, U., Rodland, K. D., Mori, M. T., Druker, B., Singer, J. W. & Agarwal, A., Mar 29 2018, (Accepted/In press) In : Leukemia. p. 1-14 14 p.

Research output: Contribution to journalArticle

Interleukin-1 Receptor-Associated Kinases
Acute Myeloid Leukemia
Myeloid Cells
Therapeutics
Heterografts
1 Citation (Scopus)

Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation

Tognon, C. E., Rafn, B., Cetinbas, N. M., Kamura, T., Trigo, G., Rotblat, B., Okumura, F., Matsumoto, M., Chow, C., Davare, M., Pollak, M., Mayor, T. & Sorensen, P. H., Jan 1 2018, In : Journal of Biological Chemistry. 293, 32, p. 12502-12515 14 p.

Research output: Contribution to journalArticle

Somatomedin Receptors
Oncogene Proteins
Receptor Protein-Tyrosine Kinases
Somatomedins
Degradation